Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 152

1.

Clinical and imaging features distinguishing Susac syndrome from primary angiitis of the central nervous system.

Marrodan M, Acosta JN, Alessandro L, Fernandez VC, Carnero Contentti E, Arakaki N, Kohler AA, Fiol MP, Ameriso SF, Correale J.

J Neurol Sci. 2018 Dec 15;395:29-34. doi: 10.1016/j.jns.2018.09.029. Epub 2018 Sep 26.

PMID:
30273791
2.

Impact of sex hormones on immune function and multiple sclerosis development.

Ysrraelit MC, Correale J.

Immunology. 2018 Sep 17. doi: 10.1111/imm.13004. [Epub ahead of print] Review.

PMID:
30222193
3.

Brain and spinal cord lesion criteria distinguishes AQP4-positive neuromyelitis optica and MOG-positive disease from multiple sclerosis.

Bensi C, Marrodan M, González A, Chertcoff A, Osa Sanz E, Chaves H, Schteinschnaider A, Correale J, Farez MF.

Mult Scler Relat Disord. 2018 Oct;25:246-250. doi: 10.1016/j.msard.2018.08.008. Epub 2018 Aug 9.

PMID:
30144694
4.

Consensus recommendations for the diagnosis and treatment of primary progressive multiple sclerosis in Latin America.

Cristiano E, Rojas JI, Abad P, Adoni T, Barahona J, Becker J, Carrá A, Flores J, Fruns M, Fernández Liguori N, Garcea O, García Bónito J, Giunta D, Gracia F, Hamuy F, Macias Islas MA, Navas C, Boschetti LO, Patrucco L, Sato DK, Correale J.

J Neurol Sci. 2018 Oct 15;393:4-13. doi: 10.1016/j.jns.2018.07.024. Epub 2018 Jul 31. Review.

PMID:
30096568
5.

Effects of Systolic Blood Pressure on Brain Integrity in Multiple Sclerosis.

Dossi DE, Chaves H, Heck ES, Rodriguez Murúa S, Ventrice F, Bakshi R, Quintana FJ, Correale J, Farez MF.

Front Neurol. 2018 Jun 25;9:487. doi: 10.3389/fneur.2018.00487. eCollection 2018.

6.

Metabolic coupling of axons and glial cells: Implications for multiple sclerosis progression.

Correale J, Ysrraelit MC, Benarroch EE.

Neurology. 2018 Apr 17;90(16):737-744. doi: 10.1212/WNL.0000000000005339. Epub 2018 Mar 21. No abstract available.

PMID:
29661892
7.

New fungal infections associated with disease-modifying treatments in MS.

Correale J.

Mult Scler. 2018 Jun;24(7):1004-1006. doi: 10.1177/1352458518770090. Epub 2018 Apr 13. No abstract available.

PMID:
29649933
8.

Evolution of multiple sclerosis prevalence and phenotype in Latin America.

Negrotto L, Correale J.

Mult Scler Relat Disord. 2018 May;22:97-102. doi: 10.1016/j.msard.2018.03.014. Epub 2018 Mar 21. Review.

PMID:
29649790
9.

Corrigendum to "Argentinean recommendations on the identification of treatment failure in relapsing remitting multiple sclerosis patients" [J. Neurol. Sci. 385C (2018) 217-224].

Cristiano E, Alonso R, Alvez Pinheiro A, Bacile EA, Balbuena ME, Ballario C, Barboza AG, Bestoso S, Burgos M, Cáceres F, Carnero Contentti E, Carrá A, Crespo E, Curbelo MC, Deri N, Fernandez J, Fernández Liguori N, Fiol M, Gaitán MI, Garcea O, Giunta D, Halfon MJ, Hryb JP, Jacobo M, Kohler E, Linares R, Luetic GG, Martínez AD, Míguez J, Nofal PG, Patrucco L, Piedrabuena R, Rojas JI, Rotta Escalante R, Saladino ML, Silva BA, Sinay V, Steinberg JD, Tarulla A, Vétere SA, Villa A, Vrech C, Ysrraelit MC, Correale J.

J Neurol Sci. 2018 Apr 15;387:231-232. doi: 10.1016/j.jns.2018.02.003. Epub 2018 Feb 12. No abstract available.

PMID:
29449007
10.

Argentinean recommendations on the identification of treatment failure in relapsing remitting multiple sclerosis patients.

Cristiano E, Alonso R, Alvez Pinheiro A, Bacile EA, Balbuena ME, Ballario C, Barboza AG, Bestoso S, Burgos M, Cáceres F, Carnero Contentti E, Carrá A, Crespo E, Curbelo MC, Deri N, Fernandez J, Fernández Liguori N, Fiol M, Gaitán MI, Garcea O, Giunta D, Halfon MJ, Hryb JP, Jacobo M, Kohler E, Linares R, Luetic GG, Martínez AD, Míguez J, Nofal PG, Patrucco L, Piedrabuena R, Rojas JI, Rotta Escalante R, Saladino ML, Silva BA, Sinay V, Steinberg JD, Tarulla A, Vétere SA, Villa A, Vrech C, Ysrraelit MC, Correale J.

J Neurol Sci. 2018 Feb 15;385:217-224. doi: 10.1016/j.jns.2018.01.004. Epub 2018 Jan 4. Review. Erratum in: J Neurol Sci. 2018 Feb 12;:.

PMID:
29406907
11.

Quality of Life Assessment in Multiple Sclerosis: Different Perception between Patients and Neurologists.

Ysrraelit MC, Fiol MP, Gaitán MI, Correale J.

Front Neurol. 2018 Jan 11;8:729. doi: 10.3389/fneur.2017.00729. eCollection 2017.

12.

Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria.

Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, Correale J, Fazekas F, Filippi M, Freedman MS, Fujihara K, Galetta SL, Hartung HP, Kappos L, Lublin FD, Marrie RA, Miller AE, Miller DH, Montalban X, Mowry EM, Sorensen PS, Tintoré M, Traboulsee AL, Trojano M, Uitdehaag BMJ, Vukusic S, Waubant E, Weinshenker BG, Reingold SC, Cohen JA.

Lancet Neurol. 2018 Feb;17(2):162-173. doi: 10.1016/S1474-4422(17)30470-2. Epub 2017 Dec 21. Review.

PMID:
29275977
13.

Follow-on products for treatment of multiple sclerosis in Latin America: An update.

Correale J.

J Neurol Sci. 2017 Oct 15;381:153-159. doi: 10.1016/j.jns.2017.08.3242. Epub 2017 Aug 24. Review.

PMID:
28991670
14.

The challenges and opportunities of multiple sclerosis care in Latin America.

Ontaneda D, Correale J.

Mult Scler J Exp Transl Clin. 2017 Sep 25;3(3):2055217317720845. doi: 10.1177/2055217317720845. eCollection 2017 Jul-Sep. No abstract available.

15.

Gastrointestinal compromise in Susac Syndrome.

Marrodan M, Correale J, Alessandro L, Arakaki N, Rennebohm R, Kohler AA, Fiol MP.

J Neurol Sci. 2017 Aug 15;379:318-320. doi: 10.1016/j.jns.2017.06.040. Epub 2017 Jun 27. No abstract available.

PMID:
28716271
16.

Neutropenia in Patients With Multiple Sclerosis Treated With Alemtuzumab.

Gaitán MI, Ysrraelit MC, Correale J.

JAMA Neurol. 2017 Sep 1;74(9):1143-1144. doi: 10.1001/jamaneurol.2017.1456. No abstract available.

PMID:
28715536
17.

Susac Syndrome: A differential diagnosis of white matter lesions.

Marrodan M, Correale J, Alessandro L, Amaya M, Fracaro ME, Köhler AA, Fiol M.

Mult Scler Relat Disord. 2017 Jul;15:42-46. doi: 10.1016/j.msard.2017.04.007. Epub 2017 May 3.

PMID:
28641772
18.

Environmental factors influencing multiple sclerosis in Latin America.

Correale J, Farez MF, Gaitán MI.

Mult Scler J Exp Transl Clin. 2017 Jun 13;3(2):2055217317715049. doi: 10.1177/2055217317715049. eCollection 2017 Apr-Jun.

19.

Comment on extensive white matter lesions after 2 years of fingolimod: Progressive multifocal leukoencephalopathy or MS relapse?

Gaitán MI, Correale J.

Mult Scler. 2017 Apr;23(4):617-618. doi: 10.1177/1352458516682859. Epub 2016 Dec 14. No abstract available.

PMID:
28273765
20.

Amino Acid Catabolism in Multiple Sclerosis Affects Immune Homeostasis.

Negrotto L, Correale J.

J Immunol. 2017 Mar 1;198(5):1900-1909. doi: 10.4049/jimmunol.1601139. Epub 2017 Jan 27.

Supplemental Content

Loading ...
Support Center